S. Hawley

First name
S.
Last name
Hawley
Khalid, S., Calderon-Larranaga, S., Sami, A., Hawley, S., Judge, A., Arden, N., et al. (2022). Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Osteoporos Int. http://doi.org/10.1007/s00198-021-06262-1
Hawley, S., Leal, J., Delmestri, A., Prieto-Alhambra, D., Arden, N. K., Cooper, C., et al. (2016). Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis. J Bone Miner Res. http://doi.org/10.1002/jbmr.2882
Shah, A., Prieto-Alhambra, D., Hawley, S., Delmestri, A., Lippett, J., Cooper, C., et al. (2017). Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study. Osteoporos Int. http://doi.org/10.1007/s00198-016-3811-4
Leal, J., Gray, A. M., Hawley, S., Prieto-Alhambra, D., Delmestri, A., Arden, N. K., et al. (2017). Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study. J Bone Miner Res. http://doi.org/10.1002/jbmr.2995
Martin-Merino, E., Petersen, I., Hawley, S., Alvarez-Gutierrez, A., Khalid, S., Llorente-Garcia, A., et al. (2018). Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK. Osteoporos Int. http://doi.org/10.1007/s00198-017-4308-5
Garriga, C., Pazianas, M., Hawley, S., Delmestri, A., Prieto-Alhambra, D., Cooper, C., & Judge, A. (2018). Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study. Ann N Y Acad Sci. http://doi.org/10.1111/nyas.13589
Martin-Merino, E., Calderon-Larranaga, A., Hawley, S., Poblador-Plou, B., Llorente-Garcia, A., Petersen, I., & Prieto-Alhambra, D. (2018). The impact of different strategies to handle missing data on both precision and bias in a drug safety study: a multidatabase multinational population-based cohort study. Clin Epidemiol. http://doi.org/10.2147/clep.s154914
Hawley, S., Cordtz, R., Dreyer, L., Edwards, C. J., Arden, N. K., Delmestri, A., et al. (2018). Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis. Semin Arthritis Rheum. http://doi.org/10.1016/j.semarthrit.2017.09.006
Khalid, S., Calderon-Larranaga, S., Hawley, S., Ali, M. S., Judge, A., Arden, N., et al. (2018). Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Clin Epidemiol. http://doi.org/10.2147/clep.s164112
Hawley, S., Edwards, C. J., Arden, N. K., Delmestri, A., Cooper, C., Judge, A., & Prieto-Alhambra, D. (2019). Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records. Semin Arthritis Rheum. http://doi.org/10.1016/j.semarthrit.2019.08.008